Brezu ®

Formulations: 5mcg/mL syrup

Indications: Relief of dyspnea & other symptoms caused by resp obstructive disturbance in bronchial asthma, chronic bronchitis, & pulmonary emphysema. Acute bronchitis.

Dosage and Direction for Use Adult : Adult 50 mcg (10 mL) once daily at bedtime or bid. Children ≥6 yr 25 mcg (5 mL) once daily at bedtime or bid, <6 yr 1.25 mcg/kg (0.25 mL/kg) bid or tid.

Special Precaution: Patients w/ hyperthyroidism, HTN, heart disease, DM. Not a substitute for inhaled corticosteroids & other anti-inflammatory agents. Instruct patient/guardian not to abruptly reduce the dosage or stop use & switch to monotherapy unless instructed by physician. May develop acute asthma episodes during long-term management of bronchial asthma, chronic bronchitis & pulmonary emphysema. Continuous administration in excessive amounts may cause cardiac arrhythmia & arrest. W/draw the drug 12 hr prior to allergen tests. Pregnancy. Interrupt treatment during lactation. Low birth wt infants & neonates. Elderly.

Adverse Reaction: Shock or anaphylactoid reaction; significant decrease in serum K levels. Palpitations, tachycardia; tremor, headache; nausea, vomiting; skin rash.

Interactions: Potential induction of arrhythmias w/ catecholamines (eg, adrenaline & isoprenaline). Decrease in serum K levels & aggravate CV adverse reactions w/ xanthine derivatives (eg, theophylline, aminophylline &
diprophylline). May excessively decrease serum K levels w/ corticosteroids (eg, betamethasone, prednisolone & hydrocortisone Na succinate) & diuretics (eg, furosemide).

Presentation/Packaging: Syrup 5 mcg/mL x 60 mL

For more information on this product, please see the product insert.